Posted in | News | Quantum Dots

Nanoco Welcomes Decision by MEPs to Reject Cadmium in Quantum Dots

Nanoco Group plc, a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, confirms that Members of the European Parliament (“MEPs”) have overwhelming voted against a proposed extension of an exemption to the Restriction of Hazardous Substances Directive (RoHS) which would have allowed the use of cadmium-containing quantum dots in Europe.

Nanoco welcomes this decision by MEPs owing to the threat posed by cadmium to human health and to the environment.

“We are very pleased by this decision by the European Parliament and we would like to thank MEPs for the time they have taken to understand the detail and implications of the proposed exemption, said Michael Edelman, CEO, Nanoco. “Cadmium-free quantum dots are without question the preferred choice for human and environmental health. Such quantum dots have significant technological benefits and they are available today. We look forward to their increasingly widespread use throughout Europe, and worldwide, in multiple applications including enhanced LCD displays.”

ABOUT NANOCO
Nanoco (LSE: NANO) is a world leader in the development and production of cadmium-free quantum dots and other nano-materials for use in multiple applications including lighting, LCD displays, solar cells and bio-imaging. In the display market, it has an exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development offices in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate. For further information please visit: www.nanocogroup.com.

Source: http://www.nanocotechnologies.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.